NO980473D0 - Use of fluconazole to inhibit cancer growth - Google Patents

Use of fluconazole to inhibit cancer growth

Info

Publication number
NO980473D0
NO980473D0 NO980473A NO980473A NO980473D0 NO 980473 D0 NO980473 D0 NO 980473D0 NO 980473 A NO980473 A NO 980473A NO 980473 A NO980473 A NO 980473A NO 980473 D0 NO980473 D0 NO 980473D0
Authority
NO
Norway
Prior art keywords
fluconazole
cancer growth
inhibit cancer
inhibit
growth
Prior art date
Application number
NO980473A
Other languages
Norwegian (no)
Other versions
NO980473L (en
Inventor
James Berger Camden
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/674,180 external-priority patent/US5908855A/en
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO980473D0 publication Critical patent/NO980473D0/en
Publication of NO980473L publication Critical patent/NO980473L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO980473A 1995-08-04 1998-02-03 Use of fluconazole to inhibit cancer growth NO980473L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US188995P 1995-08-04 1995-08-04
US08/674,180 US5908855A (en) 1996-07-16 1996-07-16 Compositions for treating viral infections
PCT/US1996/012474 WO1997005873A2 (en) 1995-08-04 1996-07-30 Use of fluconazole for inhibiting the growth of cancers

Publications (2)

Publication Number Publication Date
NO980473D0 true NO980473D0 (en) 1998-02-03
NO980473L NO980473L (en) 1998-04-03

Family

ID=26669622

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980473A NO980473L (en) 1995-08-04 1998-02-03 Use of fluconazole to inhibit cancer growth

Country Status (18)

Country Link
EP (1) EP0841921A2 (en)
JP (1) JPH11510187A (en)
KR (1) KR19990036138A (en)
CN (1) CN1195288A (en)
AR (1) AR003175A1 (en)
AU (1) AU711966B2 (en)
BR (1) BR9609966A (en)
CA (1) CA2229024A1 (en)
CZ (1) CZ33798A3 (en)
HU (1) HUP9903420A3 (en)
IL (1) IL123095A0 (en)
MX (1) MX9800998A (en)
NO (1) NO980473L (en)
NZ (2) NZ315184A (en)
PL (1) PL324904A1 (en)
SK (1) SK14198A3 (en)
TR (2) TR199801739T2 (en)
WO (1) WO1997005873A2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
FR2742405B1 (en) * 1995-12-13 1998-02-27 Cgea Comp Gen Entre Auto DRIVE UNIT COULD BE COUPLED TO A ROLLING SPEAKER AND RESULTING VEHICLE
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
PE11499A1 (en) * 1997-05-16 1999-03-01 Procter & Gamble TREATMENT OF HIV AND CANCER
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
KR20010103655A (en) * 1998-11-09 2001-11-23 케네쓰 제이. 울코트 Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-cd20 antibody
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US7004915B2 (en) * 2001-08-24 2006-02-28 Kci Licensing, Inc. Negative pressure assisted tissue treatment system
EP1895012A1 (en) 2006-08-30 2008-03-05 Universitätsklinikum Freiburg Method for inducing tumor apoptosis by increasing nitric oxide levels
WO2008073961A2 (en) * 2006-12-12 2008-06-19 Emory University Compounds and methods for modulating the silencing of a polynucleotide of interest
WO2019185521A1 (en) * 2018-03-26 2019-10-03 Westfälische Wilhelms-Universität Münster Ergosterol-biosynthesis inhibitor and influenza virus infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0196855A3 (en) * 1985-03-29 1989-04-12 Pfizer Inc. Tioconazole and related compounds for prevention of sexually transmitted diseases and control of herpetic infections
BE1004029A6 (en) * 1990-11-22 1992-09-08 Mol Omer De Pharmaceutical compound and pharmaceutical set for the treatment of cancer
US5565478A (en) * 1994-03-14 1996-10-15 The United States Of America As Represented By The Department Of Health & Human Services Combination therapy using signal transduction inhibitors with paclitaxel and other taxane analogs
US5665751A (en) * 1995-06-07 1997-09-09 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers

Also Published As

Publication number Publication date
TR199800270T1 (en) 1998-05-21
AU711966B2 (en) 1999-10-28
CA2229024A1 (en) 1997-02-20
BR9609966A (en) 1999-02-02
WO1997005873A3 (en) 1997-03-27
AR003175A1 (en) 1998-07-08
IL123095A0 (en) 1998-09-24
PL324904A1 (en) 1998-06-22
SK14198A3 (en) 1999-03-12
EP0841921A2 (en) 1998-05-20
AU6683396A (en) 1997-03-05
NZ503921A (en) 2002-03-01
NO980473L (en) 1998-04-03
MX9800998A (en) 1998-04-30
JPH11510187A (en) 1999-09-07
KR19990036138A (en) 1999-05-25
NZ315184A (en) 2000-05-26
HUP9903420A3 (en) 2001-12-28
TR199801739T2 (en) 1998-12-21
WO1997005873A2 (en) 1997-02-20
CZ33798A3 (en) 1998-06-17
CN1195288A (en) 1998-10-07
HUP9903420A2 (en) 2000-03-28

Similar Documents

Publication Publication Date Title
NO980473D0 (en) Use of fluconazole to inhibit cancer growth
NO980420D0 (en) Use of griseofulvin to inhibit cancer growth
NO940083L (en) Communication system over power supply lines to reduce the effect of signal cancellation
DE69427756D1 (en) INHIBITION OF HAIR GROWTH
NO973009D0 (en) Method of inhibiting cathepsin-k
DE69617652D1 (en) REDUCTION OF HAIR GROWTH
NO980419D0 (en) Use of 1H, 2,4-triazole derivatives to inhibit cancer growth
AU6956696A (en) Uses of tfpi inhibitor for treatment of cancer
DE69613818D1 (en) INHIBITION OF HYDRATE FORMATION
NO975761L (en) Method of inhibiting hydrate formation
NO971895D0 (en) Inhibitors of apolipoprotein <beta> synthesis
NO975589L (en) Method of inhibiting hydrate formation
PL321680A1 (en) Derivatives of proline useful as inhibitors of human leucocytes elastase
NO996324D0 (en) Process for the preparation of intermediates in the synthesis of benzopyran compounds
NO975668D0 (en) Method of preventing hydrate formation
NO975581D0 (en) Steps to reduce bone loss
NO973455D0 (en) Dermatological use of Vitamin-D derivatives
NO972848D0 (en) Neat way of making noodles
EP0827506A4 (en) Synthesis of glycopolymers
NO976024D0 (en) Use of N-cyclohexylbenzamides to treat bowel disorders
NO940190L (en) Use of alpha-ketoglutarate
DE69633529D1 (en) Determination of the adjustment bit
NO973609D0 (en) Method of inhibiting the effects of IL-6
NO973963D0 (en) Steps to inhibit ovarian cancer
MX9205491A (en) REGIOSELECTIVE SYNTHESIS OF 1,5-DIARIL PIRAZOL ANTI-INFLAMMATORY AGENTS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application